Breaking down language, channel and process barriers in cross-border care — making the best doctors your personal doctors.
300 Grade-A partner hospitals · 3,000+ leading experts · one-stop service across all specialties
Tuberculous empyema results from Mycobacterium tuberculosis infection of the pleural cavity with purulent exudate accumulation. Acid-fast bacilli are often found in pleural fluid smears or cultures (70%). Chronic empyema often forms due to delayed diagnos
传染科Tuberculous encapsulated empyema (A16.500x010) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compile
Tuberculous pleurisy (retreatment) (A16.500x009) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compi
Tuberculous pleurisy (new case) (A16.500x008) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled
Tuberculous pleurisy, without mention of bacteriological or histological confirmation (A16.500) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a de
Tuberculous bronchopleural fistula (A16.405) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Vocal cord tuberculosis (A16.403) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Tracheal tuberculosis (A16.402) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Epiglottic tuberculosis (A16.401) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Tuberculous bronchial stenosis (A16.400x011) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Tuberculous tracheal stenosis (A16.400x010) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Endobronchial tuberculosis (A16.400x007) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Isolated tracheobronchial tuberculosis (A16.400x005) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being c
Isolated tracheal tuberculosis (A16.400x004) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Tuberculous bronchial fistula (A16.400x001) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Tuberculosis of larynx, trachea and bronchi, without mention of bacteriological or histological confirmation (A16.400) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National
Mediastinal lymph node tuberculosis (A16.305) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled
Bronchial lymph node tuberculosis (A16.304) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Tracheobronchial lymph node tuberculosis (A16.303) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being com
Intrathoracic lymph node tuberculosis (A16.302) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compil
|